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Abstract: 
Objectives: The research objective is the determination of the frequency of etiological agents like Neisseria 
meningitides, Haemophilus influenza, and Streptococcus pneumonia in Acute Bacterial Meningitis having CSF-
culture as ‘positive’. To determine the survival frequency of Acute Bacterial Meningitis patients. 
Material and Methods: We conducted this case-series study at Medicine Department of Services Hospital, Lahore 
(January 2017 to September 2017). We selected 292 patients having Acute Bacterial Meningitis for our study. 
Results: We recorded (39.98 ± 17.57) years of mean age among patients. The number of patients with Streptococcus 
pneumonia, Neisseria meningitides, and Haemophilus influenza was 52% (153), 36% (105), and 12% (34) 
respectively. We recorded 82% (239) with survival and 18% (53) patients expired. 
Conclusion: The study concludes that SP is the most common EA that causes ABM. The number of male victims of 
ABM is higher than that of the females though survival has no association with gender. The age of the patient 
significantly associates with survival. 
Keywords: Acute Bacterial Meningitis (ABM), Streptococcus Pneumonia (SP), Haemophilus Influenza (HI), 
Cerebrospinal Fluid (CSF), Neisseria Meningitides (NM), Etiological Agents (EA), and Invasive Meningococcal 
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INTRODUCTION: 
ABM is an acute purulent-infection of sub-arachnoid 
space. Among all dreadful CNS infections, this carries 
a high morbidity and mortality rate [1]. Each year, 1.2 
million cases come to diagnosis globally [2]. A 
significant portion of High Dependency/Medical Units 
at hospitals include patients with this disease. Causes 
of ABM among adults are SP, NM, HI, Klebsiella, 
Gram-Negative Bacilli Escherichia, and 
Staphylococcus aureus [3]. A study shows the 
percentage of SP, NM, and HI to be 47.49%, 33.90%, 
and 19.20% respectively among 121 ABM patients 
[4]. Proteus and Listeria monocytogenes are fewer 
common causes whereas Streptococcal viridians, 
Streptococci (Group-B) and Acinetobacter are rare 
causes. The spectrum of clinical presentation of ABM 
is wider, including altered sensorium, fever, neck 
stiffness, and headache. ABM has 68% of 
complication rate, which is very high [5]. Hemiplegia, 
seizures, intracranial thrombosis, hydrocephalus, and 
cranial-nerve palsies are some common compilations. 
ABM carries a 14% mortality rate where (19 to 37%), 
10% and 5% are the rates of SP, NM, and HI 
respectively [6]. Generally, ABM mortality risk 
increases with decreased-level of consciousness (at 
presentation), old age (> 50 years), seizures 
(admission within one day), delayed 
diagnosis/treatment, raised intracranial pressure, and 
co-morbidities (diabetes-mellitus included). Other 
predictions include CSF glucose decreased (< 40 mg), 
and increased CSF protein level (> 300 mg/ml) [7]. 
ABM diagnosis complete examination of CSF and 
Culture, Sensitivity, and CSF Gram-stain are used for 
the identification of EA. CSF-culture produced (70 to 
90%) positive case-rate for EA of ABM [8]. Finding 
out the markedly raised intracranial-pressure or SOL 
(Space Occupying Lesion) brain through fundoscopy 
and brain, CT scan is prudent before the performance 
of diagnostic-LP (Lumbar Puncture). Our study 
intends to determine ABM’s common EA’s frequency 
taking CSF-culture, clinical outcome and sensitivity as 
a basis. Through this, the treating physicians will 
explore more causes of prevalence and complications 
among patients of ABM. 
 
Bacterial growth of a kind recorded on sample of CSF-
culture like SP (Gram-positive capsulated-diplococci 
of lancet shape gram-positive on Gram-stain; the 
forming of rounded, small alpha-hemolytic colonies in 
blood-agar), NM (Gram-negative capsulated-cocci of 
the shape of kidney beans pain on Gram-stain; forms 
oxidase-positive colonies in chocolate on culture), and 
HI (Gram-negative capsulated-rods on Gram-stain; 
enriched chocolate agar colonies formed on culture i-
e Factor V and Heme enriched). A professor of 
Microbiology from Pathology Dept. confirmed these 
findings [9]. 
 
Patients having neck rigidity of fewer than seven days, 
history of a headache, fever of > 1000 F, meningitis 
irritation like Kernig sign (hamstring muscle pain 
during knee extension) neck stiffness (pain/resistance 
on flexing neck passively), altered sensorium 
(Glasgow Coma scale decreased score < 15/15). The 
diagnostic lumbar puncture showing presence of CSF 
proteins (> 45 mg/ml), CSF glucose (< 40 mg/ml or 
simultaneous serum-glucose level <40%), WBCs (> 
100/ml with neutrophilic pleocytosis > 50% in CSF) 
[7]. If a patient dies within after 24 hours while being 
under ABM treatment, with 7 days, is considered 
mortality. 
 
MATERIAL AND METHODS: 
We conducted this case-series study at Medicine 
Department of Services Hospital, Lahore (January 
2017 to September 2017). We selected 292 patients 
having Acute Bacterial Meningitis for our study. Our 
inclusion criteria were, both gender patients of (15 to 
65) years age, having CSF-culture positive ABM. We 
excluded patients with partial treatment of ABM, 
evidence of intracranial haemorrhage or SOL in CT-
Brain, CSF with lymphocytic pleocytosis (> 50%) for 
viral meningoencephalitis, Cerebral-malaria (MP +ve 
Blood-film), Haematological malignancy (lymphoma 
and leukaemia), Systemic-Lupus-Erythematosis 
(ANA-serum positive), and Tuberculous meningitis 
(ZN Stain Positive CSF). 
 
We selected 292 patients who were fulfilling the 
criteria of inclusion. We took informed consent from 
each patient. We collected name, gender, age, and 
registration of hospital in a proforma. We admitted 
ABM patients in the hospital. We put the patients in 
either recumbent-position or sitting. We ensured anti-
septic measures and anaesthesia and performed 
diagnostic lumber-puncture in (L4/L5 or L3/L4) 
intervertebral-space to achieve CSF (10 mL) for C/E, 
culture & sensitivity and Grams-stain. We used a 
sterile bottle for the collection of the sample and 
sending it to Dept. of Pathology of the hospital. We 
inoculated CSF in chocolate, blood and thiomartin 
agar plates. We entered the clinical outcome, 
sensitivity, and CSF-culture in the patient’s proforma. 
We used SPSS to enter and analyse the data. We 
calculated the mean and standard deviation for 
numerical data (hospital duration and age). We 
calculated frequencies for every EA (SP, NM, and HI) 
and survival. We did age, duration at the hospital, and 
gender stratification, applied Chi-square test to check 
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significance level considering P-value significant as ≤ 
0.5. 
 
RESULTS: 
In our study, the mean age of the patients was (39.9 ± 
17.5) years. Among 292 ABM patients, we detected 
SP, NM, and HI among 52.4% (153), 35.9% (105), and 
11.6% (34) patients respectively. In our study, 82% 
(239) patients survived whereas 18% (53) patients 
expired. The survival rate among patients with SP, 
NM, and HI was 75.8% (116), 90.4% (95), and 82.3% 
(28) patients respectively with P-value as 0.011 
significant. We found an association between patients’ 
survival and EA. After gender stratification, we found 
the survival rate among male and female patients as 
82.5% (147) and 80.70% (92) patients out 60.9% (178) 
and 39% (114) patients respectively with insignificant 
P-value as 0.684. We also found an association 
between patients’ survival and gender. We divided 
patients into 02 age-groups; (15-40) and (41-65) years. 
The rate among (15-40) and (41-65) year’s age-group 
was 90.3% (133) and 73.10% (106) out of 50.3% 
(147), and 49.6% (145) patients respectively. The 
association of age with survival rate was significant 
with p-value = 0.000. We make two groups of the 
duration of stay at the hospital as (1-3) and (4-7) days’ 
group. The number of patients in group (1-3) days and 
(4-7) days’ groups were 51% (149) and 49% (143) 
respectively. The rate of survival was 17.50% (26) for 
(1-3) days’ group and 18.8% (27) for (4-7) days’ 
group. We found an insignificant association (P-value 
= 0.764) between survival rate and hospital-stay 
duration. We did age stratification relative to EA 
pattern. We made two age groups, (15-40) and (41-65) 
years. Among the patients (147) or (15-40) year’s age-
group, we found 51% (75), 38.76% (57) and 10.2% 
(15) patients with SP, NM, and HI respectively. 
Among the patients (145) or (41-65) year’s age-group, 
we found 53.8% (78), 33.10% (48) and 13.10% (19) 
patients with SP, NM, and HI respectively. The 
association between EA and age was insignificant with 
P-value = 0.525. Among 60.9% (178) male patients, 
we found SP, NM, and HI rate to be 51.1% (91), 34.8% 
(62), and 14% (25) patients respectively. Among 39% 
(114) male patients, we found SP, NM, and HI rate to 
be 54.39% (62), 37.7% (43), and 7.9% (9) patients 
respectively. The association between gender and EA 
pattern was insignificant with P-value of 0.278. 
Among (1-3) days’ hospital stay group patients (149), 
we found the rate of SP, NM, and HI to be 49% (73), 
37.5% (56) 13.4% (20) patients respectively. Among 
(4-7) days’ hospital stay group patients (143), we 
found the rate of SP, NM, and HI to be 55.9% (80), 
34.2% (49) and 9.8% (14) patients respectively. The 
association between hospital duration and EA was 
insignificant with P-value of 0.423. 
 
Table – I: Etiological Agents Pattern 
 
Etiological Agents Pattern Number Percentage 
Streptococcus Pneumoniae 153 52 
Neisseria Meningitides 105 36 
Hemophilus Influenzae 34 12 
 
 
Table – II: Survival Rate Stratification 
 
Survival Number Percentage 
Yes 239 82 
No 53 18 
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Table – III: Etiological Agent, Age, Gender and Hospital Stay Stratification 
 
Etiological Agent, Age, Gender and 
Hospital Stay Stratification 
Yes No Total  
P-Value 
No % No % No % 
Etiological 
Agents 
Streptococcus Pneumoniae  37 24.18 116 75.82 153 52.4 
0.011 
Neisseria Meningitides  10 9.52 95 90.48 105 35.96 
Hemophilus Influenzae  6 17.65 28 82.35 34 11.64 
Total  53 18.15 239 81.85 292 100 
Age 
15 - 40 Years 14 9.52 133 90.48 147 50.34 
0.000 41 - 65 Years 39 26.9 106 73.1 145 49.66 
Total 53 18.15 239 81.85 292 100 
Gender 
Male 31 17.42 147 82.58 178 60.96 
0.684 Female 22 19.3 92 80.7 114 39.04 
Total 53 18.15 239 81.85 292 100 
Hospital 
Stay 
1 - 3 Days 26 17.5 123 82.5 149 51 
0.764 4 - 7 Days 27 18.88 116 81.12 143 49 
Total  53 18.15 239 81.85 292 100 
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Table – IV: Age, Gender and Hospital Stay Stratification among Etiological Agents 
 
Age, Gender 
and Hospital Stay 
Streptococcus 
Pneumonia 
Neisseria 
Meningitides 
Hemophilus 
Influenza 
Total 
P-Value 
No % No % No % No % 
Age 
15 - 40 Years 75 51.02 57 38.76 15 10.2 147 50.34 
0.525 41 - 65 Years 78 53.79 48 33.1 19 13.1 145 49.66 
Total  153 52.4 105 35.96 34 11.64 292 100 
Male  91 51.12 62 34.83 25 14.04 178 60.96 
0.278 
Gender 
Female  62 54.39 43 37.72 9 7.89 114 39.04 
Total  153 52.4 105 35.96 34 11.64 292 100 
Hospital 
Stay 
1 - 3 Days 73 49 56 37.58 20 13.42 149 51.03 
0.423 4 - 7 Days 80 55.94 49 34.27 14 9.79 143 48.97 
Total  153 52.4 105 35.96 34 11.64 292 100 
 
 
 
 
DISCUSSION: 
The infection of membranes that surrounds spinal-cord 
and brain is termed as meningitis. There is multiple 
aetiology involved in meningitis like fungal, viral, or 
bacterial but bacteria are the common EA among them. 
Meningitis varies from being acute (quick symptoms 
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on-set), chronic (lasting months), aseptic, or mild but 
identifying its cause is of vital importance to start 
appropriate intervention [9]. ABM is a life-threatening 
disease with high mortality and morbidity rate around 
the world, especially among developing countries [10, 
11]. In our study, the mean age of the patients was 
(39.9 ± 17.5) years. Ahmad et al. reports (41 ± 12.30) 
years mean age in his study [12]. In our study, among 
292 ABM patients, we detected SP, NM, and HI 
among 52.4% (153), 35.9% (105), and 11.6% (34) 
patients respectively. Abdulrab et al. took 121 ABM 
patients and performed a lumbar puncture in 92.60% 
(112) patients [4]. He found the rate of SP (+ve 
culture), NM, and HI to be 47.40%, 33.90%, and 
10.20% respectively, which is in similarity with our 
study. Ahmad et al. found the rate of SP, and NM to 
be 36.80% (35), and 31.50% (30) respectively, which 
is in favour of our study [12]. Abro et al. find the rate 
of NM, SP, Staph. Aureus, Klebsiella Pneumonia, 
Strept. Agalactiae, and E. Coli to be 54.70% (29), 
33.96% (18), 3.7% (02), 3.77% (02), 1.8% (01) and 
1.80% (01) respectively [13]. These results are not 
similar to our study as the common-agent is NM in this 
study instead of SP. In our study, 82% (239) patients 
survived whereas 18% (53) patients expired. Abdulrab 
et al. show a 22.30% mortality rate among ABM 
patients which is similar to our study outcome [4]. 
Abro et al. reported a lower mortality rate comparing 
to our study which is 07.54% [13]. In our study, ABM 
shows male dominance with more male victims than 
female. Same is the case with the studies of Ahmad et 
al. and Abro et al. with the number of male and female 
ABM patients to be 84.2% and 15.7% respectively 
[12]. 
 
CONCLUSION: 
Our study concludes that SP is the common-most EA 
causing ABM with male dominance (more male 
victims than female). There is a significant association 
of survival rate with patients’ age, however, no 
association with the patient’s gender. 
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